|
|
Volumn 23, Issue 3, 2005, Pages 267-
|
|
A dose of reality for rational therapies
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
CELL CYCLE PROTEIN;
CETUXIMAB;
CYCLINE;
CYTOTOXIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
ERYTHROPOIETIN;
GEFITINIB;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
IMATINIB;
MAMMALIAN TARGET OF RAPAMYCIN;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
MONOCLONAL ANTIBODY;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN KINASE B;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
RAF PROTEIN;
RAS PROTEIN;
STEM CELL FACTOR RECEPTOR;
TRASTUZUMAB;
BIOTECHNOLOGY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER THERAPY;
CHROMOSOME REARRANGEMENT;
CHRONIC MYELOID LEUKEMIA;
DRUG TARGETING;
EDITORIAL;
GASTROINTESTINAL STROMAL TUMOR;
GENE MUTATION;
HUMAN;
LEUKEMIA;
LUNG NON SMALL CELL CANCER;
MULTIPLE MYELOMA;
PRIORITY JOURNAL;
SIDE EFFECT;
SIGNAL TRANSDUCTION;
DRUG APPROVAL;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG INDUSTRY;
METHODOLOGY;
NEOPLASM;
RESEARCH;
UNITED STATES;
MAMMALIA;
ANTIBODIES, MONOCLONAL;
DRUG APPROVAL;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
NEOPLASMS;
PROTEIN KINASE INHIBITORS;
RESEARCH;
UNITED STATES;
|
|
EID: 33544461936
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0305-267 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|